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Diverse microbial ecosystems underpin life in the sea. Among these microbes are many unicellular eukaryotes that span the 
diversity of the eukaryotic tree of life. However, genetic tractability has been limited to a few species, which do not represent 
eukaryotic diversity or environmentally relevant taxa. Here, we report on the development of genetic tools in a range of pro-
tists primarily from marine environments. We present evidence for foreign DNA delivery and expression in 13 species never 
before transformed and for advancement of tools for eight other species, as well as potential reasons for why transformation 
of yet another 17 species tested was not achieved. Our resource in genetic manipulation will provide insights into the ancestral 
eukaryotic lifeforms, general eukaryote cell biology, protein diversification and the evolution of cellular pathways.
The ocean represents the largest continuous planetary ecosys-tem, hosting an enormous variety of organisms, which include microscopic biota such as unicellular eukaryotes (protists). 
Despite their small size, protists play key roles in marine biogeo-
chemical cycles and harbor tremendous evolutionary diversity1,2. 
Notwithstanding their significance for understanding the evolution 
of life on Earth and their role in marine food webs, as well as driv-
ing biogeochemical cycles to maintain habitability, little is known 
about their cell biology including reproduction, metabolism and 
signaling3. Most of the biological knowledge available is based on 
comparison of proteins from cultured species to homologs in genet-
ically tractable model taxa4–7. A main impediment to understand-
ing the cell biology of these diverse eukaryotes is that protocols for 
genetic modification are only available for a small number of spe-
cies8,9 that represent neither the most ecologically relevant protists 
nor the breadth of eukaryotic diversity.
The development of genetic tools requires reliable information 
about gene organization and regulation of the emergent model spe-
cies. Over the last decade, genome4–6 and transcriptome sequenc-
ing initiatives7 have resulted in nearly 120 million unigenes being 
identified in protists10, which facilitates the developments of genetic 
tools used for model species. Insights from these studies enabled the 
phylogenetically informed approach7 for selecting and developing 
key marine protists into model systems in the Environmental Model 
Systems (EMS) Project presented herein. Forty-one research groups 
took part in the EMS Project, a collaborative effort resulting in the 
development of genetic tools that significantly expand the number 
of eukaryotic lineages that can be manipulated, and that encompass 
multiple ecologically important marine protists.
Here, we summarize detailed methodological achievements and 
analyze results to provide a synthetic ‘transformation roadmap’ for 
creating new microeukaryotic model systems. Although the organ-
isms reported here are diverse, the paths to overcome difficulties 
share similarities, highlighting the importance of building a well-
connected community to overcome technical challenges and accel-
erate the development of genetic tools. The 13 emerging model 
species presented herein, and the collective set of genetic tools from 
the overall collaborative project, will not only extend our knowl-
edge of marine cell biology, evolution and functional biodiversity, 
but also serve as platforms to advance protistan biotechnology.
Results
Overview of taxa in the EMS initiative. Taxa were selected from 
multiple eukaryotic supergroups1,7 to maximize the potential of cel-
lular biology and to evaluate the numerous unigenes with unknown 
functions found in marine protists (Fig. 1). Before the EMS initia-
tive, reproducible transformation of marine protists was limited to 
only a few species such as Thalassiosira pseudonana, Phaeodactylum 
tricornutum and Ostreococcus tauri (Supplementary Table 1). The 
EMS initiative included 39 species, specifically, 6 archaeplastids, 
2 haptophytes, 2 rhizarians, 9 stramenopiles, 12 alveolates, 4 disco-
bans and 4 opisthokonts (Fig. 1). Most of these taxa were isolated 
from coastal habitats, the focus area of several culture collections7. 
More than 50% of the selected species are considered photoauto-
trophs, with another 35% divided between heterotrophic osmotro-
phs and phagotrophs, the remainder being predatory mixotrophs. 
Almost 20% of the chosen species are symbionts and/or parasites of 
marine plants or animals, 5% are associated with detritus and several 
are responsible for harmful algal blooms (Supplementary Table 2).
While some transformation systems for protists have been devel-
oped in the past8,9,11, the challenge for this initiative was to develop 
genetic tools for species that not only require different cultivation 
conditions but are also phenotypically diverse. It should be noted 
that not all main lineages were explored. For example, amoebo-
zoans did not feature in this aquatic-focused initiative, in part 
because they tend to be most important in soils, at least based on 
current knowledge, and manipulation systems exist for members 
of this eukaryotic supergroup, such as Dictyostelium discoideum12. 
The overall EMS initiative outcomes are summarized in Fig. 1 and 
Table 1. We provide detailed protocols for 13 taxa, for which no 
transformation systems have been previously reported (category A) 
and eight taxa, for which existing protocols9,11,13–21 were advanced 
(category B; Figs. 2, 3 and 4, Table 1, Supplementary Tables 1–5 and 
Methods). We also review an already published EMS transforma-
tion protocol22 in one species (category C), and we discuss unsuc-
cessful transformation attempts for 17 additional taxa (Fig. 1 and 
Methods). Finally, we synthesize our findings in a roadmap for the 
development of transformation systems in protists (Fig. 5).
Archaeplastids. Prasinophytes are important marine green algae dis-
tributed from polar to tropical regions23. They form a sister group to 
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chlorophyte algae, and together, these two groups branch adjacent to 
land plants, collectively comprising the Viridiplantae, which are part 
of the Archaeplastida1,23 (Fig. 1). Genome sequences are available for 
the picoprasinophytes (<3 µm cell diameter) tested herein, specifi-
cally, Micromonas commoda, M. pusilla, Ostreococcus lucimarinus and 
Bathycoccus prasinos. As part of the EMS initiative, we report on genetic 
tools for Bathycoccus, a scaled, nonmotile genus, and Micromonas, 
a motile, naked genus with larger genomes than Bathycoccus and 
Ostreococcus22. We also report on genetic tools for Tetraselmis striata 
and O. lucimarinus. The latter was transformed based on an adapted 
homologous recombination system for O. tauri24,25.
O. lucimarinus (RCC802) and B. prasinos (RCC4222) were trans-
formed using protocols adapted from O. tauri24,25. Briefly, using 
electroporation for transfer of exogenous genes, O. lucimarinus was 
transformed using a DNA fragment encoding the O. tauri high-
affinity phosphate transporter (HAPT) gene fused to a luciferase 
gene and a kanamycin selection marker (Table 1 and Supplementary 
Table 3), which resulted in transient luciferase expression 24 h after 
electroporation (Table 1 and Fig. 3a). After 2 weeks of growth in 
low-melting agarose plates containing G418 (1 mg ml−1), 480 colo-
nies were obtained, picked and grown in artificial seawater with the 
antibiotic neomycin. Of these, 76 displayed luminescence ≥2.5-fold 
above background (80 relative luminescence units (RLU)), with 
widely variable levels (200–31,020 RLU), likely reflecting either 
variations in the site of integration and/or the number of integrated 
genes (Fig. 3a, Supplementary Fig. 1 and Methods).
The O. tauri construct did not work in B. prasinos, while the 
use of the B. prasinos histone H4 and HAPT sequences in an oth-
erwise identical construct and conditions was successful. Although 
luciferase expression was not detected 24 h after electroporation, 
48 G418-resistant colonies were obtained 2 weeks later, 20 being 
luminescent when grown in liquid medium. Analysis of 14 resistant 
transformants revealed that the luciferase sequence was integrated 
into the genome of five luminescent clones, and one nonlumines-
cent clone (Fig. 3b and Methods), suggesting that the chromatin 
context at integration sites in the latter was not favorable to lucif-
erase expression.
Although transformation methods successful for Bathycoccus and 
Ostreococcus failed in Micromonas, Lonza nucleofection was success-
ful with M. commoda (CCMP2709) (Table 1 and Fig. 3c) using two 
different codon-optimized plasmids, one encoding the luciferase 
gene (NanoLuc, Promega) flanked by an exogenous promoter and 
terminator sequence from the 5′ and 3′ untranslated regions (UTRs) 
of histone H3 in Micromonas polaris (CCMP2099), and the other 
encoding an enhanced green fluorescent protein (eGFP) gene flanked 
by endogenous promoter and terminator sequences from ribosomal 
protein S9 (Supplementary Table 5). Sensitivities to antibiotics were 
established (Supplementary Table 3). Constructs did not include a 
selectable marker, as we aimed to introduce and express foreign DNA 
while developing conditions suitable for transfection that supported 
robust growth in this cell wall-lacking protist (Table 1). Transformants 
revealed a significantly higher level of eGFP fluorescence than wild-
type cells, with 1.3% of the population showing fluorescence per cell 
45-fold higher than both the nontransformed portion of the culture 
and the wild-type cells (Fig. 3c and Methods). Additionally, the RLU 
was 1,500-fold higher than controls when using the luciferase-bear-
ing construct, such that multiple experiments with both plasmids 
confirmed expression of exogenous genes in M. commoda.
T. striata (KAS-836) was transformed using microprojectile bom-
bardment (Supplementary Fig. 2a). Two selectable marker genes 
were tested, consisting of a putative promoter and 5′ UTR sequences 
from the T. striata actin gene and either the coding sequences of 
the Streptoalloteichus hindustanus bleomycin gene (conferring 
resistance to zeocin) or the Streptomyces hygroscopicus bar gene 
(conferring resistance to glufosinate) (Table 1, Supplementary Fig. 2a 
and Methods). The terminator sequence was obtained from the 
T. striata glyceraldehyde-3-phosphate dehydrogenase gene. 
Linearized plasmids were coated on gold particles and introduced 
into T. striata cells by using the PDS-1000/He Particle Delivery 
System (Bio-Rad). Transformants were successfully selected on half-
strength f/2 at 50% salinity agar plates containing either 150 μg ml−1 
zeocin or 150 μg ml−1 glufosinate.
Haptophytes (incertae sedis). Haptophytes are a group of photosyn-
thetic protists that are abundant in marine environments and include 
the principal calcifying lineage, the coccolithophores. Genome 
sequences are available for Emiliania huxleyi6 and Chrysochromulina 
tobin26, and there is one report of nuclear transformation of a calci-
fying coccolithophore species27 but transformation of E. huxleyi, the 
most prominent coccolithophore, has not been achieved yet27. Here, 
as part of the EMS initiative, a stable nuclear transformation system 
was developed for Isochrysis galbana, a species that lacks coccoliths, 
but represents an important feedstock for shellfish aquaculture28.
I. galbana (CCMP1323) was transformed by biolistic bom-
bardment with the pIgNAT vector, which contains nourseothricin 
(NTC) N-acetyltransferase (NAT), (for nourseothricin resistance) 
driven by the promoter and terminator of Hsp70 from E. huxleyi  
(CCMP1516). Twenty-four hours after bombardment, cells were 
transferred to liquid f/2 medium at 50% salinity containing 
80 µg ml−1 NTC and left to grow for 2–3 weeks to select for trans-
formants (Table 1). The presence of NAT in NTC-resistant cells 
was verified by PCR and PCR with reverse transcription (RT–PCR) 
(Fig. 4a, Supplementary Fig. 2b and Methods) and the sequence was 
verified. To confirm NTC resistance was a stable phenotype, cells 
were subcultured every 2–4 weeks at progressively higher NTC con-
centrations (up to 150 µg ml−1) in the above-mentioned media. Cells 
remained resistant to NTC for approximately 6 months, as con-
firmed by PCR screening to identify the presence of the NAT gene.
Rhizarians. Rhizarians include diverse nonphotosynthetic protists, 
as well as the photosynthetic chlorarachniophytes that acquired a 
plastid via secondary endosymbiosis of a green alga4. Uniquely, they 
represent an intermediate stage of the endosymbiotic process, since 
their plastids still harbor a relict nucleus (nucleomorph). Here, we 
report on an advanced transformation protocol for the chlorarach-
niophyte Amorphochlora (Lotharella) amoebiformis for which low-
efficiency transient transformation has previously been achieved 
using particle bombardment14.
A. amoebiformis (CCMP2058) cells were resuspended in 100 µl 
of Gene Pulse Electroporation Buffer (Bio-Rad) with 20–50 µg of 
the reporter plasmid encoding eGFP-RubisCO fusion protein under 
the control of the native rbcS1 promoter and subjected to electro-
poration (Table 1). Cells were immediately transferred to fresh 
ESM medium and incubated for 24 h. Transformation efficiency 
was estimated by the fraction of cells expressing eGFP, resulting 
in 0.03–0.1% efficiency, as enumerated by microscopy, showing 
an efficiency up to 1,000-fold higher than in the previous study14 
(Table 1). Stable transformants were generated by manual isolation 
using a micropipette, and a transformed line has maintained eGFP 
fluorescence for at least 10 months without antibiotic selection 
(Figs. 2 and 4b and Methods).
Stramenopiles. Stramenopiles are a diverse lineage harboring impor-
tant photoautotrophic, mixotrophic (combining photosynthetic 
and phagotrophic nutrition) and heterotrophic taxa. As the most 
studied class in this lineage, diatoms (Bacillariophyceae) were early 
targets for the development of reverse genetics tool11,29. Diatoms are 
estimated to contribute approximately 20% of annual carbon 
fixation30 and, like several other algal lineages, are used in bioen-
gineering applications and biofuels31. Although other cold-adapted 
eukaryotes have, to our knowledge, yet to be transformed, here we 
present a protocol for the Antarctic diatom Fragilariopsis cylindrus32. 
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A transformation protocol has also been developed herein for 
Pseudo-nitzschia multiseries, a toxin-producing diatom33. Here 
we also present work for nondiatom stramenopiles, including a 
transformation protocol for the eustigmatophyte Nannochloropsis 
oceanica, and an alternative protocol for the labyrinthulomycete 
Aurantiochytrium limacinum20, both of which are used for bio-
technological applications. Furthermore, we report on advances 
for CRISPR/Cas-driven gene knockouts in Phaeodactylum 
tricornutum8,13 and a more efficient bacterial conjugation system for 
Thalassiosira pseudonana13.
Microparticle bombardment was used on F. cylindrus 
(CCMP1102) that was grown, processed and maintained at 4 °C 
in 24 h light. Exponential phase cells were harvested onto a 1.2 µm 
membrane filter that was then placed on an 1.5% agar Aquil plate for 
bombardment with beads coated with a plasmid containing zeocin 
resistance and eGFP, both controlled by an endogenous fucoxanthin 
chlorophyll a/c binding protein (FCP) promoter and terminator 
(Table 1, Supplementary Table 3 and Methods)34. Transformation 
was performed using 0.7 µm tungsten particles and the biolistic 
particle delivery system PDS-1000/He (Bio-Rad). Rupture disks for 
Homologous
Heterologous
Labeled DNA
mRNA
FITC–dextran
Resistance selection CRISPR/Cas9
Electroporation Conjugation MicroinjectionChemical Biolistics
D
el
iv
er
y
Sy
st
em
CO
N
ST
R
U
C
T
Glass beads
abrasion
R
Bodo saltans
Diplonema papillatum
Eutreptiella gymnastica
Naegleria gruberi
Pirum gemmata
Sphaeroforma arctica
Abeoforma whisleri
Salpingoeca rosetta
R
R
R
R
R
R
R
R
R
R
Did not work 
Fragilariopsis cylindrus
Thalassiosira pseudonana 
Seminavis robusta
Pseudo-nitzschia multiseries 
Heterosigma akashiwo 
Aurantiochytrium limacinum
Caecitellus sp. 
Nannochloropsis oceanica
Phaeodactylum tricornutum
R
R
Breviolum (Symbiodinium) sp. 
Crypthecodinium cohnii
Amphidinium carterae (chloroplast)
Karlodinium veneficum
Ostreococcus lucimarinus 
Bathycoccus prasinos 
Micromonas commoda 
Micromonas pusilla 
Tetraselmis striata
Pyramimonas parkeae
Pico-eukaryotes
Amorphochlora amoebiformis
Bigelowiella natans
Isochrysis galbana 
Emiliania huxleyi
AAAA
AAAA
R
R
R
DNA delivered and
expressed
DNA delivered 
Not yet achievedTr
an
sf
or
m
at
io
n
St
at
us
AAAA
Archaeplastids
Discobans
Haptophytans
Rhizarians
R
Euplotes crassus 
Euplotes focardii
Chromera velia
Perkinsus marinus
Oxyrrhis marina 
Hematodinium sp. 
Fugacium (Symbiodinium) kawagutii
Alexandrium catenella
AAA
A
Alveolates
Opisthokonts
Stramenopiles
Natural communities
O
O
O
CTGGTGAAA
G TCTGGCA G
TT
CG
AG
CC
CA
AT
GC
CA
TC
GG
TAGTTTCTCAACGGGTT
CT
GG
AG
CT
G
  
 
 
CTGG T GA A A GT CT
GG
CA
GT
TC
GA
GC
CC
AA
TG
CC
AT
TAGTTTCTCAACGGGTT
C
TG
GA
G
C
T G
   
 A
GG
G T
C TTC ACA
GTCA
   
 
CTGGT GA A A GT CT
GG
CA
GT
TC
GA
GC
CC
AA
TG
CC
AT
TAGTTTCTCAACGGGTT
C
TG
GA
G
C
T G
   
 A
GG
G T
C TTC ACA
GTCA
   
 
A
A
A
A
A
B14
A
B9,13
A
B15
B19
A
A
C21,22
A
A
A
B18
B20
A
B9,11
B16,17
A
A First successful transformation of a particular species
B Alternative transformation/or improvement of the existing transformation method
C Review of an already published/existing protocol
Ciliates
Chlorarachniophytes
Poriferans
Bilaterians
Cnidarians
Ctenophores
Mycetozoans
Plants
Oomycetes
Diplomonadids
Malawimonads
Acanthomyxans
Chytrids
Haptophytes
Cryptomonads
Apicomplexans
Dinoflagellates
Bicosoecidans
Phaeophytes
Raphidophytes
Diatoms
Foraminiferans
Radiolarians
Chlorophytes
Prasinophytes
Red algae
Parabasalids
Heteroloboseans
Euglenozoans
Microsporidians
Basidiomycetes
Ascomycetes
Archaemoebae
Glaucophytes
Endomyxans
Colponemids
Choanoflagellates
Ichthyosporeans
Filastereans
Ar
ch
a
ep
la
st
id
s
Rh
iza
ria
ns
Alveolates Discobans
Metamonads
Opisthokonts
A
m
o
eb
o
zoa
ns
Str
am
en
opi
les
Ha
pt
op
hy
te
s
Fig. 1 | Phylogenetic relationships and transformation status of marine protists. A schematic view of the eukaryotic tree of life with effigies of main 
representatives. Color-coordinated species we have attempted to genetically modify are listed below. Current transformability status is schematized in 
circles indicating: DNA delivered and shown to be expressed (yellow, for details see text and Table 1); DNA delivered, but no expression seen (gray) and no 
successful transformation achieved despite efforts (blue). The details of transformation of species that belong to ‘DNA delivered’ and ‘Not achieved yet’ 
categories are described in Supplementary Table 5. mRNA, messenger RNA; FITC–dextran, fluorescein isothiocyanate (FITC)-conjugated dextran.
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used for Schizochytrium36. The highest transformation efficiency 
was achieved using 1 µg of linearized 18GZG plasmid with two 
pulses, resulting in a time constant of ~5 ms (Table 1 and Methods). 
Expression of the fusion protein was confirmed by both the zeocin-
resistance phenotype and the detection of eGFP (Fig. 2). Six 18GZG 
transformants derived from uncut and linearized plasmids were 
examined in detail. All maintained antibiotic resistance through-
out 13 serial transfers, first in selective, then subsequently in non-
selective media and then again in selective medium. Integration of 
the plasmid into the genome was confirmed by PCR as well as by 
Southern blots using a digoxigenin-labeled ShBle gene probe, show-
ing that four transformants had integrations by single homologous 
recombination, while in two transformants additional copies of the 
antibiotic resistance cassette were integrated by nonhomologous 
recombination elsewhere in the genome (Supplementary Fig. 5).
Electroporation of N. oceanica (CCMP1779) was optimized 
based on observation of cells treated with fluorescein-conjugated 
2,000 kDa dextran and subsequent survival (Table 1 and Methods). 
A sorbitol concentration of 800 mM and electroporation at between 
5 and 9 kV cm−1 resulted in highest cell recovery. These conditions 
were used during introduction of plasmids containing the gene 
for the blue fluorescent reporter mTagBFP2 under the control of 
cytomegalovirus (CMV), the cauliflower mosaic virus 35S, or the 
VCP1 promoter previously described from Nannochloropsis sp.37. 
Transient expression of blue fluorescence (compared to cells elec-
troporated simultaneously under the same conditions without plas-
mid) appeared within 2 h, lasted for at least 24 h and disappeared 
by 48 h in subsets of cells electroporated with mTagBFP2 under 
the control of CMV (Supplementary Fig. 6). The transient trans-
formation was more effective when a linearized plasmid was used 
compared to a circular plasmid (Table 1). VCP1 did not induce blue 
fluorescence with a circular plasmid, while 35S gave inconsistent 
results with either circularized or linearized plasmids.
For P. tricornutum (CCAP1055/1), we adapted the CRISPR/Cas9 
system8 for multiplexed targeted mutagenesis. Bacterial conjuga-
tion13 was used to deliver an episome that contained a Cas9 cassette 
and two single-guide RNA (sgRNA) expression cassettes designed to 
excise a 38 basepair-long domain from the coding region of a nuclear-
encoded, chloroplastic glutamate synthase (Phatr3_J24739) and 
introduce an in-frame stop codon after strand ligation (Table 1 and 
Methods). The GoldenGate assembly was used to clone two expres-
sion cassettes carrying sgRNAs into a P. tricornutum episome that 
contained a Cas9–2A-ShBle expression cassette and the centromeric 
region CenArsHis (Supplementary Fig. 7). After their addition to a 
P. tricornutum culture, plates were incubated in a growth chamber 
under standard growth conditions for 2 d and transformed P. tricornu-
tum colonies began to appear after 2 weeks. Only colonies maintain-
ing Cas9–2A-ShBle sequence on the delivered episome were able to 
grow on selection plates because Cas9 and ShBle were transcription-
ally fused by the 2A peptide38 (Supplementary Fig. 7). Gel electropho-
resis migration and sequencing of the genomic target loci confirmed 
the 38 bp-long excision and premature stop codon (Fig. 4d).
Alveolates. This species-rich and diverse group comprises cili-
ates, apicomplexans and dinoflagellates (Fig. 1). As a link between 
apicomplexan parasites and dinoflagellate algae, perkinsids are 
key for understanding the evolution of parasitism, and also have 
potential biomedical applications17. Techniques currently exist 
for transformation of only a small number of ciliates, perkinsids 
and apicomplexans39. Here, we present a transformation protocol 
for Karlodinium veneficum (CCMP1975), a phagotrophic mixo-
troph that produces fish-killing karlotoxins40. Experiments were 
also performed on Oxyrrhis marina (CCMP 1788/CCMP 1795), a 
basal-branching phagotroph that lacks photosynthetic plastids and 
Crypthecodinium cohnii (CCMP 316), a heterotroph used in food 
supplements. For both of these taxa, evidence of DNA delivery 
1,350 and 1,550 pounds per square inch (psi) gave the highest col-
ony numbers with efficiencies of 20.7 colony forming units (c.f.u.) 
per 108 cells and 30 c.f.u. per 108 cells, respectively. Following bom-
bardment, the filter was turned upside down and left to recover for 
24 h on the plate, then cells were rinsed from the plate/filter and 
spread across five 0.8% agar Aquil plates with 100 µg ml−1 zeocin. 
Colonies appeared 3–5 weeks later. PCR on genomic DNA showed 
that 100 and 60% of colonies screened positive for the bleomycin 
gene (ShBle) for zeocin resistance and the gene encoding eGFP, 
respectively. As confirmed by fluorescence-activated cell sorting 
(FACS) and microscopy, eGFP was localized to the cytosol and was 
distinguishable from plastid autofluorescence (Fig. 2). Additional 
confirmation by PCR and RT–PCR (Fig. 4c) revealed that the ShBle 
and eGFP genes were present in the genomes of transformants after 
multiple transfers (>10) 2 years later, indicating long-term stability.
Bacterial conjugation methods were improved in T. pseudonana 
(CCMP1335) using the silaffin precursor TpSil3p (Table 1 and 
Methods) as the target gene. TpSil3p was fused to eGFP flanked by 
an FCP promoter and terminator, cloned into a pTpPuc3 episomal 
backbone and transformed into mobilization plasmid-containing 
EPI300 E. coli cells (Lucigen). The donor cells were grown in super 
optimal broth with catabolite repression (SOC) medium at 37 °C 
until OD600 of 0.3–0.4, centrifuged and resuspended in 267 μl SOC 
medium. Next, 200 μl of donor cells were mixed with T. pseudonana 
cells, cocultured on predried 1% agar plates, dark incubated at 
30 °C for 90 min, then at 18 °C in constant light for 4 h, followed 
by selection in 0.25% agar plates containing 100 µg ml−1 NTC. 
Colonies were observed after 2 weeks, inoculated into 300 μl L1 
medium and supplemented with 200 µg ml−1 NTC to reduce the 
number of false positives. Positive transformants were identified by 
colony PCR screening (Supplementary Fig. 3) and epifluorescence 
microscopy (Fig. 2).
The diatom P. multiseries (15093C) and other members of this 
genus form buoyant linear chains with overlapping cell tips during 
active growth, and were unconducive to punctate colony forma-
tion on agar, where their growth is generally poor. To address this 
challenge, a low-gelation-temperature agarose seawater medium 
(LGTA) was developed to facilitate growth, antibiotic selection 
and cell recovery. P. multiseries exhibited growth inhibition at rela-
tively low concentrations under NTC, formaldehyde and zeocin 
(Supplementary Table 3). Biolistic transformation of two other P. 
species had been demonstrated at low efficiency35. To complement 
this approach and explore potentially higher efficiency methods 
for transformation with diatom episomal plasmids, we modified 
the existing conjugation-based method13. The published conjuga-
tion protocol was modified to enhance P. multiseries postconjuga-
tion viability by reducing SOC content. An episomal version of the 
Pm_actP_egfp_actT expression cassette was transfected into E. coli 
EPI300+pTAMOB and used for conjugation (Table 1 and Methods). 
After 48 h in L1 medium, cells were plated in LGTA and eGFP-pos-
itive cells were observed 7 d later (Fig. 2). PCR revealed the pres-
ence of plasmids in all eGFP-positive colonies (Supplementary 
Fig. 4). Similarly, conjugation with the episome pPtPUC3 (bleo-
mycin selection marker)-containing bacterial donors was followed 
under zeocin selection (200 μg ml−1). After 7 d, only viable cells 
(based on bright chlorophyll fluorescence) contained the episome, 
as confirmed by PCR. Propagation of transformants after the first 
medium transfer (under selection) has so far been unsuccessful.
Stable transformation of A. limacinum (ATCC MYA-1381) 
was achieved by knock-in of a resistance cassette composed of 
ShBle driven by 1.3 kb promoter and 1.0 kb terminator regions of 
the endogenous glyceraldehyde-3-phosphate dehydrogenase gene 
carried in a pUC19-based plasmid (18GZG) along with the native 
18S ribosomal RNA gene, and by knock-in of a similar construct con-
taining a eGFP:ShBle fusion (Supplementary Fig. 5). Approximately 
1 × 108 cells were electroporated, adapting the electroporation protocol 
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was achieved (Table 1, Supplementary Results, Supplementary 
Fig. 15 and Methods), a goal recently achieved for C. cohnii using 
electroporation19. Additionally, we report on improved transforma-
tion systems for Perkinsus marinus (PRA240) and Amphidinium 
carterae (CCMP1314) chloroplast, published recently as part of the 
EMS initiative15.
K. veneficum (CCMP1975) was transformed based on electro-
poration and cloning the selectable marker gene aminoglycoside 
3′-phosphotransferase (nptII/neo; note that nptII/neo is used synon-
ymously with amino 3′-glycosyl phosphotransferase gene conferring 
resistance to kanamycin, neomycin, paromomycin, ribostamycin, 
butirosin and gentamicin B) into the backbone of the dinoflagellate-
specific expression vector DinoIII-neo41, which confers resistance 
to neomycin and kanamycin (Table 1). In brief, DinoIII-neo was 
linearized and electroporated using the Nucleofector optimization 
pulse codes, buffer SF/Solution I (Lonza), and 2 μg μl−1 of linearized 
DinoIII-neo. Electroporated cells were selected under 150 μg ml−1 
kanamycin 3 d postelectroporation. Fresh seawater with kanamy-
cin was added every 2 weeks to the cultures and new subcultures 
were inoculated monthly. After 3 months, DNA and RNA were iso-
lated from the resistant cultures as previously reported42 and cDNA 
was synthesized using random hexamers. Out of 16 transforma-
tions, two cell lines (CA-137, DS-138) showed stable growth under 
kanamycin selection. CA-137 developed dense cultures after 
3 months, and the resistance gene was detected in both DNA and RNA 
by nested PCR and RT–PCR, respectively (Fig. 4e, Supplementary 
Fig. 8 and Methods).
We improved the transformation protocol16,17 of P. marinus, a 
pathogen of marine mollusks, fish and amphibians43 (Supplementary 
Table 5). We coexpressed two genes and efficiently selected tran-
sient and stable transformants using FACS (Table 1, Figs. 2 and 4f, 
Supplementary Fig. 9 and Methods). In addition, we established 
the integration profile of ectopic DNA once introduced into the 
P. marinus genome. We did not see evidence of integration through 
homologous recombination and observed a propensity for plasmid 
fragmentation and integration within transposable elements sites. 
An optimized alternative protocol for transformation using glass 
bead abrasion was also developed. Two versions of the previously 
published Moe gene promoter16 were tested. Whereas the 1.0 kb pro-
moter version induced expression after 2 or 3 d, the truncated ver-
sion (0.5 kb) took 7 d for expression to be detected. Resistance genes 
to zeocin, blasticidin and puromycin have all been shown to confer 
resistance to transformed P. marinus; however, selection regimes 
are still relatively slow and inefficient, indicating further room 
for improvement17.
We also report a vector for the transformation of the A. carterae 
chloroplast, a photosynthetic dinoflagellate. A. carterae, like other 
dinoflagellates with a peridinin-containing chloroplast, contains a 
fragmented chloroplast genome made up of multiple plasmid-like 
minicircles40. The previous transformation protocols made use 
of this to introduce two vectors based on the psbA minicircle15. 
Here, we show that other minicircles are also suitable for use as vec-
tors. We created an artificial minicircle, using the atpB minicircle 
as a backbone, but replacing the atpB gene with a codon-optimized 
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Fig. 2 | epifluorescence micrographs of transformed marine protists. Representative images of transformants and wild-type cell lines of ten selected 
protist species. Colored boxes behind species names refer to phylogenetic supergroup assignments given in Fig. 1. Representative data of at least two 
independent experiments are shown. The fluorescent images show the expression of individual fluorescent marker genes introduced via transformation for 
all organisms shown, except in the case of A. amoebiformis. For this, red depicts the natural autofluorescence of photosynthetic pigments in the cell, while 
the additional green spheres in the transformant fluorescence panel shows introduced GFP fluorescence (see Supplementary Fig. 15c for a trace of these 
different regions in the cell). Scale bars are as follows: 10 µm for A. amoebiformis, T. pseudonana, A. limacinum, B. saltans, N. gruberi, A. whisleri and S. rosetta; 
15 µm for P. marinus; 20 µm for F. cylindrus and 100 µm for P. multiseries.
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chloramphenicol acetyltransferase (Table 1 and Methods). This 
circular vector was introduced by biolistics to A. carterae 
(Supplementary Fig. 10a). Following selection with chloramphen-
icol, we were able to detect transcription of the chloramphenicol 
acetyltransferase gene via RT–PCR (Fig. 4g). This result suggests 
that all 20 or so minicircles in the dinoflagellate chloroplast genome 
would be suitable for use as artificial minicircles, thus providing a 
large pool of potential vectors.
Discobans. This diverse group, recently split into Discoba and 
Metamonada44, includes heterotrophs, photoautotrophs and preda-
tory mixotrophs, as well as parasites. Discobans include parasitic 
kinetoplastids with clinical significance, such as Trypanosoma bru-
cei, T. cruzi and Leishmania spp., for which efficient transformation 
protocols are available45. However, such protocols are missing for 
aquatic species. Here, we describe available transformation pro-
tocols for the kinetoplastid Bodo saltans and the heterolobosean 
Naegleria gruberi. The former was isolated from a lake, but iden-
tical 18S rRNA gene sequences have been reported from marine 
environments46. The latter is a freshwater protist that represents a 
model organism for closely related marine heterolobosean amoe-
bas. Furthermore, we provide advanced methods that build on pre-
vious EMS results18 for the diplonemid Diplonema papillatum.
B. saltans (ATCC 30904) was transformed with a plasmid con-
taining a cassette designed to fuse an endogenous EF1-α gene with 
eGFP for C-terminal tagging. This cassette includes downstream 
of eGFP, a B. saltans tubulin intergenic region followed by the 
selectable marker nptII/neo gene, conferring resistance to neomycin. 
EF1-α genes exist in tandem repeats. The homologous regions that 
flank the cassette were chosen as targets for inducing homology-
directed repair; however, they target only one copy of the gene. As 
transcription in B. saltans is polycistronic46, insertion of the tubulin 
intergenic region into the plasmid is essential for polyadenylation 
of the EF1-α/GFP fusion and trans-splicing of the nptII/neo gene 
(Supplementary Table 5). Selection of transfected cells began with 
2 µg ml−1 of neomycin added 24 h after electroporation, and this 
concentration was gradually increased over 2 weeks to 5 µg ml−1 
(Table 1 and Methods). Cells were washed and subcultured into fresh 
selection medium every 4 d, and neomycin-resistant cells emerged 
7–9 d postelectroporation. The eGFP signal was detected 2 d post-
electroporation, albeit with low intensity. This may be due to the 
inefficient translation of eGFP since it has not been codon-optimized 
for B. saltans (Fig. 2). Genotyping analysis 9 months posttrans-
fection confirmed the presence of the nptII/neo gene and at least 
partial plasmid sequence (Fig. 4h and Supplementary Fig. 10b). 
However, plasmid integration into the B. saltans genome through 
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homologous recombination is still unconfirmed. This suggests 
either off-target plasmid integration or episomal maintenance.
For N. gruberi (ATCC 30224) two plasmids were designed. The 
first one carried the hygromycin B resistance gene (hph) with an 
actin promoter and terminator, along with an HA-tagged eGFP 
driven by the ubiquitin promoter and terminator. The second plas-
mid carried the nptII/neo gene instead. For each individual circular 
plasmid, 4 μg was electroporated (Table 1 and Methods). About 48 h 
after electroporation, dead cells were removed from the suspension 
and viable cells were washed with PBS. Afterward, 300 μg ml−1 of 
hygromycin B or 700 μg ml−1 of neomycin was added to the fresh 
media. One to 4 weeks later, resistant clones were recovered and 
expression of eGFP and/or hygromycin was confirmed by western 
blotting (Supplementary Fig. 11). Expression of eGFP was observed 
by epifluorescence microscopy (Fig. 2 and Supplementary Fig. 11) 
with ~80% of transformants maintaining hygromycin B or neomy-
cin resistance in addition to expressing eGFP.
D. papillatum (ATCC 50162) was transformed by electroporation 
using 3 μg of a SwaI-linearized fragment (cut from p57-V5+NeoR 
plasmid) containing the V5-tagged nptII/neo gene flanked by 
partial regulatory sequences derived from the hexokinase gene 
of the kinetoplastid Blastocrithidia (strain p57) (Table 1 and 
Methods) using a published protocol18. About 18 h after electropor-
ation, 75 μg ml−1 G418 was added to the medium and after 2 weeks, 
seven neomycin-resistant clones were recovered. Transcription of 
nptII/neo was verified in four clones by RT–PCR (Supplementary 
Fig. 12) and the expression of the tagged nptII/neo protein was 
confirmed in two clones by western blotting using the α-V5 anti-
body (Fig. 4i).
Opisthokonts. The opisthokont clade Holozoa includes animals 
and their closest unicellular relatives choanoflagellates, filastere-
ans, ichthyosporeans and corallochytreans. The establishment of 
genetic tools in nonmetazoan holozoans promises to help illumi-
nate the cellular and genetic foundations of animal multicellular-
ity47. Genomic and transcriptomic data are available for multiple 
representatives characterized by diverse cell morphologies, some of 
which can even form multicellular structures46. Until recently, only 
transient transformations had been achieved for some opistokonts 
such as the filasterean Capsaspora owczarzaki48, the ichthyosporean 
Creolimax fragrantissima49 and the choanoflagellate Salpingoeca 
rosetta21. Through the EMS initiative, we report on evidence for 
transient transformation of the ichthyosporean Abeoforma whisleri, 
isolated from the digestive tract of mussels, and review a recently 
published stable transformation protocol for S. rosetta achieved by 
using the selectable puromycin N-acetyl-transferase gene (Fig. 2)22.
All A. whisleri life stages are highly sensitive to a variety of meth-
ods for transformation. However, we developed a 4D-nucleofection-
based protocol using 16-well strips, wherein PBS-washed cells were 
resuspended in 20 μl of buffer P3 (Lonza) containing 40 μg of carrier 
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plasmid (empty pUC19) and 1–5 μg of the reporter plasmid 
(A. whisleri H2B fused to mVenus fluorescent protein, mVFP) 
(Table 1 and Methods), and subjected to code EN-138 (Lonza). 
Immediately after the pulse, cells were recovered by adding 80 μl of 
marine broth (Gibco) before plating in 12-well culture plates previ-
ously filled with 1 ml marine broth. After 24 h, ~1% of the culture 
was transformed based on the fraction of cells expressing mVFP in 
the nucleus (Figs. 2 and 4j).
Microbial eukaryotes in natural planktonic communities. Model 
organisms are typically selected based on criteria such as relative 
ease of isolation and asexual cultivation in the laboratory; however, 
these attributes may not correlate with the capacity for uptake and 
expression of the exogenous DNA. We explored whether natural 
marine planktonic pico- and nanoeukaryote communities would 
take up DNA in a culture-independent setting. Microbial plankton 
from natural seawater was concentrated and electroporated with 
plasmids containing mTagBFP2 under the control of CMV or 35S 
promoters (Supplementary Results and Methods). In most trials, 
blue fluorescent cells were rare if detected at all (compared to con-
trol samples). However, in one natural community tested, a pho-
tosynthetic picoeukaryote population exhibited up to 50% of cells 
with transient expression of blue fluorescence when the CMV pro-
moter was used (Supplementary Fig. 13). This suggests it might be 
possible to selectively culture eukaryotic microorganisms based on 
capacity to express exogenous DNA.
discussion
The collaborative effort by the EMS initiative facilitated identifica-
tion and optimization of the steps required to create new protist 
model systems, which culminated in the synthetic transformation 
roadmap (Fig. 5). Our genetic manipulation systems for aquatic 
(largely marine) protists will enable deeper insights into their cell 
biology, with potentially valuable outcomes for aquatic sciences, 
evolutionary studies, nanotechnology, biotechnology, medicine 
and pharmacology. Successes and failures with selectable markers, 
transformation conditions and reporters were qualitatively com-
pared across species (Supplementary Tables 3 and 4, Table 1, Figs. 
2–4 and  Methods).
For some of the selected species, the first step was to identify 
cultivation conditions for robust growth in the laboratory to either 
generate high cell densities or large culture volumes for obtaining 
sufficient biomass required for a variety of molecular biology exper-
iments. Unlike established microbial model species, cultivation of 
marine protists can be challenging, especially under axenic condi-
tions or for predatory taxa that require cocultivation with their prey. 
Nevertheless, 13 out of 35 species were rendered axenic before the 
development of transformation protocols. For the remaining spe-
cies, we were unable to remove bacteria and therefore had to make 
sure that transformation signals were coming from the targeted pro-
tist rather than contaminants (Supplementary Table 2). Subsequent 
steps included the identification of suitable antibiotics and their 
corresponding selectable markers (Table 1 and Supplementary 
Table 3), conditions for introducing exogenous DNA (Table 1 and 
Supplementary Table 4) and selection of promoter and terminator 
sequences for designing transformation vectors (Table 1, Methods, 
Supplementary Table 5 and Supplementary Notes 1).
As exemplified in the model systems provided herein (Table 1 
and Figs. 2–4), a variety of methods were used to test whether exog-
enous DNA was integrated into the genome or maintained as a plas-
mid, and whether the introduced genes were expressed. Approaches 
to show the former included inverse PCR, Southern blotting and 
whole genome sequencing, whereas approaches to demonstrate the 
latter included various combinations of PCR, RT–PCR, western 
blotting, epifluorescence microscopy, FACS, antibody-based meth-
ods and/or growth assays in the presence of antibiotics to confirm 
transcription and translation of introduced selection and reporter 
genes (for example, eGFP, YFP, mCherry). For fluorescent mark-
ers, it was first ensured that the wild-type, or manipulated controls 
cells, had no signals conflicting with the marker (Figs. 2 and 3c), an 
important step because photosynthetic protists contain chlorophyll 
and other autofluorescent pigments. Overall transformation out-
comes for each species were parsed into three groups according to 
the level of success or lack thereof (A, first transformation protocol 
for a given species; B, advanced protocol based on previous work 
and C, published protocol based on the EMS initiative) and are dis-
cussed according to their phylogenetic position (Fig. 1).
Our studies did not result in a universally applicable protocol 
because transformability and a range of other key conditions var-
ied greatly across taxa and approaches, such as intrinsic features 
of the genome and differences in cellular structure and morphol-
ogy. In general, electroporation proved to be the most common 
method for introducing exogenous DNA stably into cells. This 
approach was used for naked cells and protoplasts, yet frequently 
also worked, albeit with lower efficiency, on cells protected by cell 
walls. Linearized plasmids were most effective for delivery, and 
5′ and 3′ UTR-containing promotors of highly expressed endog-
enous genes provided the strongest expression of selective reporters 
and markers. If successful, teams usually continued with fluores-
cence-based methods. Furthermore, large amounts of carrier DNA 
usually facilitated successful initial transformations (for example, M. 
commoda, A. whisleri) or improved existing protocols (S. rosetta21). 
We also provide the contact details of all coauthors who are assigned 
to particular species (Supplementary Table 6).
Some lineages were difficult to transform, especially dinofla-
gellates and coccolithophores. Here, even if DNA appeared to be 
delivered (Supplementary Table 5), expression of the transformed 
genes could not be confirmed. Examples include the dinoflagel-
lates C. cohnii, Symbiodinium microadriaticum and the coccolitho-
phore E. huxleyi. Thus, at least these three species need concerted 
future efforts.
The combination of results presented herein together with pre-
viously published protocols from the EMS initiative50 significantly 
expands the segment of extant eukaryotic diversity amenable to reverse 
genetics approaches. Out of the 39 microbial eukaryotes selected for 
the initiative, exogenous DNA was delivered and expressed in more 
than 50% of them. The transformation systems enable us to shed 
light on the function of species-specific genes, which likely reflect key 
adaptations to specific niches in dynamic ocean habitats.
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Methods
Studied species and used transformation methods. For the full list of vector 
sequences and maps see Supplementary Notes 1 and for detailed description of 
Figs. 3 and 4 see Supplementary Note 2. Antibiotic concentrations effective for 
selection of transformants can be found in Supplementary Table 3, the details of 
the transformation methods applied to this study in Supplementary Table 4 and 
contact details for individual laboratories in Supplementary Table 6. Full list of 
protists (including details of culture collection) and links to the complete step-
by-step transformation protocols and published vector sequences are listed in 
Supplementary Table 5. The protocols.io links listed in Table 1 and Supplementary 
Table 5 are summarized in Supplementary Tables 7 and 8.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
data availability
The data that support the findings of this study are available from the 
corresponding authors as well as the other authors upon request (for the contacts 
see Supplementary Table 6). Source data for Figs. 3 and 4 and Supplementary  
Figs. 9b,c, 11a and 12b,c are available online.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection FACS softwares noted in our methods section are FloJo v.10.6.1, WinList 3D v7.0 (Verity Software House) and BD FACS Sortware 
v1.2.0.142.
Data analysis FACS softwares noted in our methods section that were used for data analysis after collection on the FACS instrument are FloJo v.10.6.1 
and WinList 3D v7.0 (Verity Software House).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data that support the findings of this study are available from the corresponding authors as well as the other authors upon request (for the contacts see Suppl. 
Table 5). 
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Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No sample size calculation was performed, rather standard practices in the field of genetics were used which involved replicating experiments 
the sample sizes and replication are the same or more than in most publications presenting developments in genetic techniques. 
Data exclusions No data was excluded from the analyses.
Replication For each experiment, all attempts at replication were successful. 
Randomization The experiments were designed to determine whether a specific protocol rendered transformation in cells. Since clonal cell lines and the 
same starting material were used under pulse conditions/plasmids and negative controls and because these are not survey experiments 
randomization is not an appropriate aspect of the design
Blinding Blinding was not appropriate to our study as all measurement were performed using the same clonal cell lines and analyzed with identical 
methodologies (within each experiment). Our experiments did not involve testing placebos nor were they what is termed randomized 
controlled trials (RCT) as appropriate in e.g. drug clinical trials.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems
n/a Involved in the study
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Clinical data
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used Commercial antibodies: 
Anti-V5 tag Monoclonal Antibody (2F11F7) 
Supplier: Invitrogen  
Catalog number: 37-7500 
LOT number: 1468908A 
Dilution: 1:1,000 
 
Monoclonal Anti-α-Tubulin 
clone DM1A produced in mouse, ascites fluid 
Supplier: Sigma Aldrich 
Catalog Number: T9026 
Lot #: N/A 
Dilution: 1:2,000 
 
Anti-GFP Living Colors® A.v. Monoclonal Antibody  
Supplier: Takara 
Cat. #: 632380 
Clone name: JL-8 
Lot #: N/A 
Dilution: 1:1,000 
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Anti-GFP polyclonal antibody, Invitrogen  
Cat.no. A11122  
Clone name N/A  
Lot no. 1828014  
Dilution 1:1000  
 
Anti-Histone H3 antibody, Abcam  
Cat.no. ab1791  
Clone name N/A (polyclonal)  
Lot no. N/A  
Dilution 1:1000  
 
Anti-mCherry antibody, Abcam  
Cat.no. ab167453  
Clone name N/A (polyclonal)  
Lot no. GR3213077-5  
Dilution 1:1000  
 
HYGROMYCIN PHOSPHOTRANSFERASE ANTIBODY (10-1421) (anti-hygromycin antibody, Fitzgerald Industries) 
Host Mouse 
Clone M1709Hy4 
Isotype IgG1 
Purity > 95% pure 
Form & Buffer 
Supplied in 50mM NaCl, 10 mM Gly-HCl, 0.05% NaN3 
Dilution: 1:2000 
 
H9658- Monoclonal Anti-HA antibody produced in mouse (Sigma) 
clone HA-7 
Mouse IgG1 by RID  
Protein by Biuret  
WB-Cell Line/Tissue Extract 
Dilution: 1:10,000 
 
Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in rabbit 
Supplier: Sigma Aldrich 
Catalog Number: A9044 
Lot #: N/A 
Dilution: 1:2,000 
 
Anti-Rabbit IgG (whole molecule)–Peroxidase antibody produced in goat 
Supplier: Sigma Aldrich 
Catalog Number: A6154 
Lot #: N/A 
Dilution: 1:2,000 
 
Anti-Mouse IgG, HRP-Linked Whole Ab Sheep (secondary antibody) 
Supplier: GE Healthcare 
Cat. #: NA931-100UL 
Clone name: N/A 
Lot #:  380748 
Dilution: 1:10,000  
 
Goat Anti-rabbit HRP, ImmunoReagents Inc. (secondary antibody) 
Cat. no. GtxRb-003-DHRPX  
Clone name N/A  
Lot no. N/A  
Dilution 1:10000
Validation Validation of anti-V5 tag Monoclonal Antibody (2F11F7): The manufacturer states that the antibody works on a wide range of 
species (human, bovine, amphibian and mouse cells or tissues as well as with yeast or fungi). https://www.thermofisher.com/
antibody/product/V5-Tag-Antibody-clone-2F11F7-Monoclonal/37-7500 
We tested it on D. papillatum and T. brucei.  
 
Validation of Monoclonal Anti-α-Tubulin: Manufacturer´s validation: Monoclonal Anti-α-Tubulin is immunospecific for tubulin as 
determined by indirect immunofluorescent staining and immunoblotting procedures. The manufacturer states that the antibody 
works on a wide range of species (human, bovine, amphibian and mouse cells or tissues as well as with yeast or fungi). https://
www.sigmaaldrich.com/catalog/product/sigma/t9026?lang=en&region=CZ 
We tested it on D. papillatum and T. brucei.  
 
Validation of Anti-GFP Living Colors® A.v. Monoclonal Antibody: Manufacturer's validation: The quality and performance of Living 
Colors A.v. Monoclonal Antibody (JL-8) was tested by Western blot analysis using lysate made from a HEK 293 cell line stably 
expressing AcGFP1.  
 
Validation of Anti-GFP polyclonal antibody (Invitrogen): The manufacturer states that the antibody works on a wide range of 
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species, we tested it on T. gondii and Perkinsus in our lab.  
 
Validation of Anti-Histone H3 antibody (Abcam): validated to work with a wide range of species according to the manufacturer, 
including other alveolate species such as T. gondii and dinoflagellates as tested by our lab.  
 
Validation of Anti-mCherry antibody (Abcam): The manufacturer states this antibody to be species independent. This antibody 
works on alveolate organisms P. falciparum and T. gondii.  
 
Validation of HYGROMYCIN PHOSPHOTRANSFERASE ANTIBODY (10-1421) (anti-hygromycin antibody, Fitzgerald Industries): 
Recombinant hygromycin phosphotransderase from E.coli 
 
Validation of H9658- Monoclonal Anti-HA antibody produced in mouse (Sigma): 
1. The quality was tested by western blot analysis in E.coli expressing HA-Tag with tiger 1:40,000 dilution  
2. In whole extract of human HEK-293T cells overexpressing N-terminal HA tagged fusion protein was separated on SDS-PAGE 
and probed with Monoclonal Anti-HA Clone: HA7 (Cat. No. H9658). 
 
For each primary antibody, these antibodies have been used in several independent experiments with consistent results. 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) Protist culture collections: Ostreococcus - RCC802; Bathycoccus - RCC4222; Micromonas - CCMP2709 and CCMP 1545; 
Tetraselmis -KAS-836; Pyramimonas - SCCAP K-0007; Isochrysis - CCMP1323; Emiliania - CCMP1516; Amorphochlora - 
CCMP2058; Bigelowiella - CCMP 2755; Fragilariopsis - CCMP1102; Thalassiosira - CCMP1335; Seminavis - DCG 0498 and 
DCG 0514; Pseudo-nitzschia - 15091C3; Heterosigma - CCMP 2393; Aurantiochytrium - ATCC MYA-1381; Nannochloropsis - 
CCMP 1779; Phaeodactylum - CCAP1055/1; Chromera - CCMP 2878; Perkinsus - ATCC PRA240; Oxyrrhis - CCMP1788 and 
CCMP1795; Fugacium - CCMP 2468; Alexandrium - CCMP BF-5; Breviolum - NIES-4271; Crypthecodinium - CCMP316; 
Amphidinium - CCMP1314; Karlodinium - CCMP1975; Diplonema - ATCC50162; Eutreptiella - SCCAP K-0333; Naegleria - 
ATCC30224; Pirum - ATCC PR-280; Sphaeroforma - ATCC PRA-297; Abeoforma - ATCC PRA-279; Salpingoeca - ATCC PRA-390.
Authentication Genome sequencing, sequencing of phylogenetic marker genes (e.g. 18S)
Mycoplasma contamination The cell lines were not tested for mycoplasma contamination. 
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used.
Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Sample preparation is fully described in the Supplementary Materials. For experiments on the stramenopile (Nannochloropsis) 
electroporation occurred with or without fluorescein dextran and with or without a plasmid containing the mTagBFP2 gene 
under different promoters. No other stains were added after electroporation prior to cytometric analysis. For experiments with 
the prasinophyte (Micromonas) no stains were used at any point and experiments were performed with an eGFP plasmid with 
promotors from Micromonas, on cells that were either electroporated or not pulsed.
Instrument BD InFlux cell sorter
Software BD FACS™ Software for data collection 
FlowJo for data analysis of stramenopiles, WinList for analysis of prasinophytes and WinList for all display panels. (please see 
above for version information).
Cell population abundance For experiments demonstrating transfection of Nannochloropsis and Micromonas in pure culture cell population abundance was 
determined using an in-line flow meter on the sample line and by weighing the samples before and after data collection. This 
information on volume run was combined with counts acquired during each run to determine the abundance per ml for each 
population observed (non-transfected, transfected). 
Because of the small sample volumes and low abundance of target cells in samples of natural communities, it was not possible to 
re-test purity of sorted samples. Instead, immediately before sorting of the sample, the sorting efficiency was confirmed to >95% 
with 3 um UR calibration beads. With the same InFlux instrument and sorting protocols, we have previously determined that 
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sorted pico-cyanobacterial populations from natural samples are >99% pure, by re-running sorted samples using trigger based 
on the FSC channel and with voltage and threshold set to be able to detect even non-fluorescent particles with approx. 2x lower 
FSC than Prochlorococcus.
Gating strategy For Micromonas: The trigger channel was Forward Scatter (FSC), to allow detection of pigmented cells (both Micromonas and 
Nannochloropsis are algae with natural chlorophyll fluorescence), dead cells, and cell detritus. No gates were applied in the data 
collection mode, only for post analysis. All cells (with plasmid in treratments either pulsed, or not pulsed) were visualized in a 
two parameter histogram of FSC vs Chlorophyll (692/40 nm bp). For means, the population of non-detrital particles (living cells) 
was gated into a second two parameter histogram of FALS vs GFP (520/35 nm bp), as well as GFP vs Chlorophyll. From there cells 
with eGFP fluorescence were analyzed as were cells with baseline eGFP fluorescence and the geometric mean of these 
fluorescences were compared, as were cell abundance in each population. 
For Nannochloropsis: The trigger channel was Forward Scatter (FSC), to allow detection of pigmented cells, dead cells, and cell 
detritus. A first gate was drawn based on FSC and Side Scatter to include particles with the optical scattering characteristics 
(related approximately to size and cell complexity) of Nannochloropsis cells. Living Nannochloropsis cells maintain high red 
fluorescence from chlorophyll, so a second gate was drawn based on chlorophyll fluorescence (692 nm, excited by the 488 nm 
laser) and FSC. In samples electroporated either with (treatment) or without plasmid DNA (sham controls), the proportion of 
celllike 
particles (based on FSC and SSC) which had chlorophyll fluorescence remained high (>95%) during the first two hours but 
had dropped to 72-85% at 24 hours, while in non-electroporated samples the proportion remained >95% for the first two hours. 
In this way, blue fluorescence related to mTagBFP2 was assessed only on cells which maintained the optical characteristics of 
healthy Nannochloropsis. 
For natural samples: The trigger channel was FSC, with voltage and threshold set to include all particles which displayed high 
yellow autofluorescence (at 580 nm) and high red autofluorescence (at 692 nm), which correspond to Synechococcus-like cells 
with yellow fluorescent phycoerythrin. In control (not electroporated) and sham-control (electroporated without plasmid), gates 
were drawn based on red fluorescence (due to chlorophyll, 692 nm excited by the 640 nm laser) and FSC as shown in 
Supplementary Fig. 6. Spherical fluorescent calibration particles (3 um Spherotech UR) were used as guides for setting FSC 
parameters to define smaller picoplancton versus cells that represent larger picoplancton or nanoplancton. Three clear 
phytoplankton "populations" (groups of particles with tightly similar optical characteristics) were visually identified and gates 
were drawn around them. The gate with lowest FSC was composed of 100% or nearly 100% cells exhibiting high yellow 
fluorescence due to phycoerythrin, so were assigned as "Cyanobacteria". The other two populations were therefore assumed to 
correspond to a type of small picophytoplankton (with FSC and pulse width well below that of 3 um calibration spheres) and 
larger picophytoplankton. These three populations together showed a clear relationship between chlorophyll fluorescence and 
FSC. Cells/particles with chlorophyll fluorescence below this relationship did not form clear groups and are assumed to represent 
non-phytoplankton, some of which can exhibit low red fluorescence due to phytoplankton prey in food vacuoles. For each time 
point, the gate to define blue fluorescent (putative BFP-expressing) cells was drawn to exclude over 95% of cells in sham-controls 
which were electroporated with dextran green (to track electroporation) but without plasmid DNA. This gate was drawn 
diagonally on 460 nm (blue fluoresence) versus 530 nm (green fluorescence) to exclude any signal that could come from 
bleedover 
of the green fluorescence of fluorescein dextran.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
